Role of Steroids in Eustachian Tube Dysfunction

Intranasal corticosteroids are not strongly supported as a primary treatment for Eustachian tube dysfunction, with recent meta-analysis showing no significant difference in tympanometric normalization compared to control treatments. 1

Understanding Eustachian Tube Dysfunction (ETD)

The Eustachian tube serves three critical functions:

Protection against secretions, germs, and sound pressure from the nasopharynx
Drainage of middle ear secretions
Pressure equalization to optimize sound conduction

ETD affects approximately 1% of adults and up to 40% of children 2. It often presents with non-specific symptoms and can be diagnosed using scoring systems such as the Eustachian Tube Score (ETS-7) for patients with intact eardrums.

Evidence for Steroid Treatment in ETD

Intranasal Corticosteroids

The most recent and highest quality evidence from a 2024 systematic review and meta-analysis of randomized controlled trials found:

No significant difference in tympanometric normalization between intranasal corticosteroids and control treatments (odds ratio 1.21,95% confidence interval 0.65-2.24) 1
Limited data quality emphasizing the need for larger, higher-quality trials

Special Considerations for ETD with Allergic Rhinitis

In patients where ETD is associated with allergic rhinitis:

Nasal inflammatory conditions are an important pathogenesis of ETD 3
Treatment with nasal glucocorticoids (mometasone furoate) and oral antihistamines has shown significant improvement in eustachian tube function as nasal symptoms subside 3
Visual Analogue Scale (VAS) scores of nasal symptoms, endoscopic scores, and ETD questionnaire scores significantly decreased after treatment (p<0.0001) 3

ETD in Children with Adenoid Hypertrophy

For children with ETD associated with adenoid hypertrophy:

Intranasal azelastine-fluticasone combination has shown effectiveness in both regression of adenoid tissue and improvement in eustachian tube function 4
After 3 months of treatment, the adenoid tissue to choana rate decreased from 82% to 37%, and Eustachian tube function scores improved significantly (p<0.05) 4

Treatment Approach for ETD

For isolated ETD without clear allergic or inflammatory components:
- Intranasal corticosteroids are not strongly supported by evidence 1
- Consider alternative approaches such as regular performance of the Valsalva maneuver 2
- For persistent cases, balloon dilation may be considered (3% minor adverse event rate) 5
For ETD with allergic rhinitis:
- Intranasal corticosteroids (such as fluticasone or mometasone) are appropriate 3
- Dosing: For adults, fluticasone propionate 50 mcg per spray, 1-2 sprays in each nostril once daily 6
- Consider adding oral antihistamines for comprehensive symptom control 3
For ETD with adenoid hypertrophy in children:
- Consider intranasal corticosteroids as initial therapy 4
- Combination therapy with azelastine-fluticasone may be particularly effective 4

Administration Technique for Intranasal Corticosteroids

Proper administration is crucial for effectiveness:

Shake the bottle well before use
Keep head tilted slightly forward
Insert the nozzle into the nostril, pointing slightly away from the septum
Spray while breathing in gently through the nose
Avoid sniffing hard after spraying
Regular, consistent use is more effective than intermittent use 6

Potential Side Effects

Most common: Local irritation, epistaxis (nosebleeds)
Less common: Nasal dryness, headache
Rare: Nasal septal perforation with long-term use
Systemic effects are minimal with recommended doses 6

Conclusion

While intranasal corticosteroids are not strongly supported for isolated ETD, they may be beneficial in specific cases where ETD is associated with allergic rhinitis or adenoid hypertrophy. Treatment should be directed at the underlying cause of ETD rather than as a primary treatment for the dysfunction itself.

What is the role of steroids, such as fluticasone propionate (fluticasone), in treating Eustachian tube dysfunction?

Help us tailor your experience